{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T01:54:53Z","timestamp":1775786093051,"version":"3.50.1"},"reference-count":132,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,8,22]],"date-time":"2022-08-22T00:00:00Z","timestamp":1661126400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,8,22]],"date-time":"2022-08-22T00:00:00Z","timestamp":1661126400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurosci. Bull."],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1007\/s12264-022-00934-6","type":"journal-article","created":{"date-parts":[[2022,8,22]],"date-time":"2022-08-22T05:02:50Z","timestamp":1661144570000},"page":"113-124","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":143,"title":["Parkinson's Disease: A Multisystem Disorder"],"prefix":"10.1007","volume":"39","author":[{"given":"Helena Nunes","family":"Costa","sequence":"first","affiliation":[]},{"given":"Ana Raquel","family":"Esteves","sequence":"additional","affiliation":[]},{"given":"Nuno","family":"Empadinhas","sequence":"additional","affiliation":[]},{"given":"Sandra Morais","family":"Cardoso","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2022,8,22]]},"reference":[{"key":"934_CR1","doi-asserted-by":"publisher","first-page":"881","DOI":"10.3390\/ijerph13090881","volume":"13","author":"S Nandipati","year":"2016","unstructured":"Nandipati S, Litvan I. Environmental exposures and Parkinson\u2019s disease. Int J Environ Res Public Health 2016, 13: 881.","journal-title":"Int J Environ Res Public Health"},{"key":"934_CR2","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.tins.2018.09.007","volume":"42","author":"ME Johnson","year":"2019","unstructured":"Johnson ME, Stecher B, Labrie V, Brundin L, Brundin P. Triggers, facilitators, and aggravators: redefining Parkinson\u2019s disease pathogenesis. Trends Neurosci 2019, 42: 4\u201313.","journal-title":"Trends Neurosci"},{"key":"934_CR3","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1186\/s12974-018-1248-8","volume":"15","author":"N Kustrimovic","year":"2018","unstructured":"Kustrimovic N, Comi C, Magistrelli L, Rasini E, Legnaro M, Bombelli R. Parkinson\u2019s disease patients have a complex phenotypic and functional Th1 bias: cross-sectional studies of CD4+ Th1\/Th2\/T17 and Treg in drug-na\u00efve and drug-treated patients. J Neuroinflammation 2018, 15: 205.","journal-title":"J Neuroinflammation"},{"key":"934_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pneurobio.2018.08.002","volume":"169","author":"Z Chen","year":"2018","unstructured":"Chen Z, Chen S, Liu J. The role of T cells in the pathogenesis of Parkinson\u2019s disease. Prog Neurobiol 2018, 169: 1\u201323.","journal-title":"Prog Neurobiol"},{"key":"934_CR5","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","volume":"30","author":"RB Postuma","year":"2015","unstructured":"Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W, et al. MDS clinical diagnostic criteria for Parkinson\u2019s disease. Mov Disord 2015, 30: 1591\u20131601.","journal-title":"Mov Disord"},{"key":"934_CR6","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/nrn.2017.91","volume":"18","author":"AHV Schapira","year":"2017","unstructured":"Schapira AHV, Chaudhuri KR, Jenner P. Erratum: non-motor features of Parkinson disease. Nat Rev Neurosci 2017, 18: 509.","journal-title":"Nat Rev Neurosci"},{"key":"934_CR7","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/S1474-4422(18)30127-3","volume":"17","author":"J Marinus","year":"2018","unstructured":"Marinus J, Zhu K, Marras C, Aarsland D, van Hilten JJ. Risk factors for non-motor symptoms in Parkinson\u2019s disease. Lancet Neurol 2018, 17: 559\u2013568.","journal-title":"Lancet Neurol"},{"key":"934_CR8","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1016\/S0140-6736(09)60492-X","volume":"373","author":"AJ Lees","year":"2009","unstructured":"Lees AJ, Hardy J, Revesz T. Parkinson\u2019s disease. Lancet 2009, 373: 2055\u20132066.","journal-title":"Lancet"},{"key":"934_CR9","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.nbd.2011.10.014","volume":"46","author":"MG Cersosimo","year":"2012","unstructured":"Cersosimo MG, Benarroch EE. Pathological correlates of gastrointestinal dysfunction in Parkinson\u2019s disease. Neurobiol Dis 2012, 46: 559\u2013564.","journal-title":"Neurobiol Dis"},{"key":"934_CR10","first-page":"541","volume":"29","author":"J Campdelacreu","year":"2014","unstructured":"Campdelacreu J. Parkinson\u2019s disease and Alzheimer disease: Environmental risk factors. Neurol Engl Ed 2014, 29: 541\u2013549.","journal-title":"Neurol Engl Ed"},{"key":"934_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.parkreldis.2015.12.008","volume":"23","author":"V Bellou","year":"2016","unstructured":"Bellou V, Belbasis L, Tzoulaki I, Evangelou E, Ioannidis JPA. Environmental risk factors and Parkinson\u2019s disease: an umbrella review of meta-analyses. Park Relat Disord 2016, 23: 1\u20139.","journal-title":"Park Relat Disord"},{"key":"934_CR12","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.lpm.2017.01.001","volume":"46","author":"A Delamarre","year":"2017","unstructured":"Delamarre A, Meissner WG. Epidemiology, environmental risk factors and genetics of Parkinson\u2019s disease. La Presse M\u00e9dicale 2017, 46: 175\u2013181.","journal-title":"La Presse M\u00e9dicale"},{"key":"934_CR13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0151841","volume":"11","author":"CB Breckenridge","year":"2016","unstructured":"Breckenridge CB, Berry C, Chang ET, Sielken RL Jr, Mandel JS. Association between Parkinson\u2019s disease and cigarette smoking, rural living, well-water consumption, farming and pesticide use: Systematic review and Meta-analysis. PLoS ONE 2016, 11: e0151841.","journal-title":"PLoS ONE"},{"key":"934_CR14","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1093\/ije\/dyx225","volume":"47","author":"C Pouchieu","year":"2018","unstructured":"Pouchieu C, Piel C, Carles C, Gruber A, Helmer C, Tual S, et al. Pesticide use in agriculture and Parkinson\u2019s disease in the AGRICAN cohort study. Int J Epidemiol 2018, 47: 299\u2013310.","journal-title":"Int J Epidemiol"},{"key":"934_CR15","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s12940-020-00624-8","volume":"19","author":"M Schneider Medeiros","year":"2020","unstructured":"Schneider Medeiros M, Reddy SP, Socal MP, Schumacher-Schuh AF, Mello Rieder CR. Occupational pesticide exposure and the risk of death in patients with Parkinson\u2019s disease: An observational study in southern Brazil. Environ Health 2020, 19: 68.","journal-title":"Environ Health"},{"key":"934_CR16","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1016\/S1474-4422(16)30230-7","volume":"15","author":"A Ascherio","year":"2016","unstructured":"Ascherio A, Schwarzschild MA. The epidemiology of Parkinson\u2019s disease: Risk factors and prevention. Lancet Neurol 2016, 15: 1257\u20131272.","journal-title":"Lancet Neurol"},{"key":"934_CR17","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.parkreldis.2014.12.017","volume":"21","author":"O Palin","year":"2015","unstructured":"Palin O, Herd C, Morrison KE, Jagielski AC, Wheatley K, Thomas GN, et al. Systematic review and meta-analysis of hydrocarbon exposure and the risk of Parkinson\u2019s disease. Park Relat Disord 2015, 21: 243\u2013248.","journal-title":"Park Relat Disord"},{"key":"934_CR18","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1002\/ana.23687","volume":"72","author":"AJ Noyce","year":"2012","unstructured":"Noyce AJ, Bestwick JP, Silveira-Moriyama L, Hawkes CH, Giovannoni G, Lees AJ, et al. Meta-analysis of early nonmotor features and risk factors for Parkinson disease. Ann Neurol 2012, 72: 893\u2013901.","journal-title":"Ann Neurol"},{"key":"934_CR19","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1002\/mds.27730","volume":"34","author":"N Bergsland","year":"2019","unstructured":"Bergsland N, Zivadinov R, Schweser F, Hagemeier J, Lichter D, Guttuso T Jr. Ventral posterior substantia nigra iron increases over 3 years in Parkinson\u2019s disease. Mov Disord 2019, 34: 1006\u20131013.","journal-title":"Mov Disord"},{"key":"934_CR20","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.jns.2018.01.008","volume":"386","author":"H An","year":"2018","unstructured":"An H, Zeng X, Niu T, Li G, Yang J, Zheng L, et al. Quantifying iron deposition within the substantia nigra of Parkinson\u2019s disease by quantitative susceptibility mapping. J Neurol Sci 2018, 386: 46\u201352.","journal-title":"J Neurol Sci"},{"key":"934_CR21","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.cbpc.2017.11.008","volume":"208","author":"AJ Green","year":"2018","unstructured":"Green AJ, Planchart A. The neurological toxicity of heavy metals: A fish perspective. Comp Biochem Physiol C Toxicol Pharmacol 2018, 208: 12\u201319.","journal-title":"Comp Biochem Physiol C Toxicol Pharmacol"},{"key":"934_CR22","doi-asserted-by":"publisher","first-page":"3383","DOI":"10.3892\/mmr.2017.6386","volume":"15","author":"G Mostile","year":"2017","unstructured":"Mostile G, Cicero CE, Giuliano L, Zappia M, Nicoletti A. Iron and Parkinson\u2019s disease: A systematic review and meta-analysis. Mol Med Rep 2017, 15: 3383\u20133389.","journal-title":"Mol Med Rep"},{"key":"934_CR23","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.neurobiolaging.2012.05.015","volume":"34","author":"S Mariani","year":"2013","unstructured":"Mariani S, Ventriglia M, Simonelli I, Donno S, Bucossi S, Vernieri F, et al. Fe and Cu do not differ in Parkinson\u2019s disease: A replication study plus meta-analysis. Neurobiol Aging 2013, 34: 632\u2013633.","journal-title":"Neurobiol Aging"},{"key":"934_CR24","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s12011-017-0941-2","volume":"179","author":"H Sun","year":"2017","unstructured":"Sun H, Liu X, Ge H, Wang T, Wang Y, Li W. Association between serum zinc levels and the risk of Parkinson\u2019s disease: A Meta-analysis. Biol Trace Elem Res 2017, 179: 45\u201351.","journal-title":"Biol Trace Elem Res"},{"key":"934_CR25","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.neulet.2015.04.010","volume":"595","author":"J Xia","year":"2015","unstructured":"Xia J, Xu H, Jiang H, Xie J. The association between the C282Y and H63D polymorphisms of HFE gene and the risk of Parkinson\u2019s disease: A meta-analysis. Neurosci Lett 2015, 595: 99\u2013103.","journal-title":"Neurosci Lett"},{"key":"934_CR26","first-page":"11","volume":"2019","author":"C Boulos","year":"1896","unstructured":"Boulos C, Yaghi N, El Hayeck R, Heraoui GN, Fakhoury-Sayegh N. Nutritional risk factors, microbiota and Parkinson\u2019s disease: What is the current evidence? Nutrients 1896, 2019: 11.","journal-title":"Nutrients"},{"key":"934_CR27","doi-asserted-by":"publisher","first-page":"13291","DOI":"10.1074\/jbc.R900010200","volume":"284","author":"T Nguyen","year":"2009","unstructured":"Nguyen T, Nioi P, Pickett CB. The Nrf2-antioxidant response element signaling pathway and its activation by oxidative stress. J Biol Chem 2009, 284: 13291\u201313295.","journal-title":"J Biol Chem"},{"key":"934_CR28","doi-asserted-by":"publisher","first-page":"471","DOI":"10.3389\/fphys.2018.00471","volume":"9","author":"SM Cardoso","year":"2018","unstructured":"Cardoso SM, Empadinhas N. The microbiome-mitochondria dance in prodromal Parkinson\u2019s disease. Front Physiol 2018, 9: 471.","journal-title":"Front Physiol"},{"key":"934_CR29","doi-asserted-by":"publisher","first-page":"501","DOI":"10.3233\/JPD-191683","volume":"9","author":"S Cerri","year":"2019","unstructured":"Cerri S, Mus L, Blandini F. Parkinson\u2019s disease in women and men: What\u2019s the difference? J Parkinsons Dis 2019, 9: 501\u2013515.","journal-title":"J Parkinsons Dis"},{"key":"934_CR30","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1016\/j.jnutbio.2012.03.005","volume":"23","author":"EE Vomhof-Dekrey","year":"2012","unstructured":"Vomhof-Dekrey EE, Picklo MJ Sr. The Nrf2-antioxidant response element pathway: A target for regulating energy metabolism. J Nutr Biochem 2012, 23: 1201\u20131206.","journal-title":"J Nutr Biochem"},{"key":"934_CR31","doi-asserted-by":"publisher","first-page":"677","DOI":"10.3233\/JPD-171175","volume":"7","author":"IY Kim","year":"2017","unstructured":"Kim IY, O\u2019Reilly \u00c9J, Hughes KC, Gao X, Schwarzschild MA, Ascherio A. Differences in Parkinson\u2019s disease risk with caffeine intake and postmenopausal hormone use. J Parkinsons Dis 2017, 7: 677\u2013684.","journal-title":"J Parkinsons Dis"},{"key":"934_CR32","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1111\/cns.12684","volume":"23","author":"M Kolahdouzan","year":"2017","unstructured":"Kolahdouzan M, Hamadeh MJ. The neuroprotective effects of caffeine in neurodegenerative diseases. CNS Neurosci Ther 2017, 23: 272\u2013290.","journal-title":"CNS Neurosci Ther"},{"key":"934_CR33","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.bcp.2019.06.008","volume":"166","author":"JP Lopes","year":"2019","unstructured":"Lopes JP, Pli\u00e1ssova A, Cunha RA. The physiological effects of caffeine on synaptic transmission and plasticity in the mouse hippocampus selectively depend on adenosine A1 and A2A receptors. Biochem Pharmacol 2019, 166: 313\u2013321.","journal-title":"Biochem Pharmacol"},{"key":"934_CR34","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.brainres.2014.11.008","volume":"1621","author":"AM Sebasti\u00e3o","year":"2015","unstructured":"Sebasti\u00e3o AM, Ribeiro JA. Neuromodulation and metamodulation by adenosine: Impact and subtleties upon synaptic plasticity regulation. Brain Res 2015, 1621: 102\u2013113.","journal-title":"Brain Res"},{"key":"934_CR35","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1159\/000502292","volume":"19","author":"N Nag","year":"2019","unstructured":"Nag N, Jelinek GA. A narrative review of lifestyle factors associated with Parkinson\u2019s disease risk and progression. Neurodegener Dis 2019, 19: 51\u201359.","journal-title":"Neurodegener Dis"},{"key":"934_CR36","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1007\/s00415-011-6302-8","volume":"259","author":"M Poletti","year":"2012","unstructured":"Poletti M, Bonuccelli U. Personality traits in patients with Parkinson\u2019s disease: Assessment and clinical implications. J Neurol 2012, 259: 1029\u20131038.","journal-title":"J Neurol"},{"key":"934_CR37","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.jns.2017.01.013","volume":"374","author":"G Santangelo","year":"2017","unstructured":"Santangelo G, Piscopo F, Barone P, Vitale C. Personality in Parkinson\u2019s disease: Clinical, behavioural and cognitive correlates. J Neurol Sci 2017, 374: 17\u201325.","journal-title":"J Neurol Sci"},{"key":"934_CR38","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.archger.2015.08.004","volume":"61","author":"X Li","year":"2015","unstructured":"Li X, Li W, Liu G, Shen X, Tang Y. Association between cigarette smoking and Parkinson\u2019s disease: A meta-analysis. Arch Gerontol Geriatr 2015, 61: 510\u2013516.","journal-title":"Arch Gerontol Geriatr"},{"key":"934_CR39","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1159\/000445751","volume":"46","author":"L Hirsch","year":"2016","unstructured":"Hirsch L, Jette N, Frolkis A, Steeves T, Pringsheim T. The incidence of Parkinson\u2019s disease: A systematic review and Meta-analysis. Neuroepidemiology 2016, 46: 292\u2013300.","journal-title":"Neuroepidemiology"},{"key":"934_CR40","doi-asserted-by":"publisher","first-page":"6251","DOI":"10.3390\/ijms20246251","volume":"20","author":"YH Chen","year":"2019","unstructured":"Chen YH, Wang V, Huang EYK, Chou YC, Kuo TT, Olson L, et al. Delayed dopamine dysfunction and motor deficits in female parkinson model mice. Int J Mol Sci 2019, 20: 6251.","journal-title":"Int J Mol Sci"},{"key":"934_CR41","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1159\/000097485","volume":"84","author":"LM Garcia-Segura","year":"2006","unstructured":"Garcia-Segura LM, Sanz A, Mendez P. Cross-talk between IGF-I and estradiol in the brain: Focus on neuroprotection. Neuroendocrinology 2006, 84: 275\u2013279.","journal-title":"Neuroendocrinology"},{"key":"934_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsbmb.2019.105421","volume":"193","author":"Y Ishihara","year":"2019","unstructured":"Ishihara Y, Sakurai H, Oguro A, Tsuji M, Vogel CFA, Yamazaki T. Retinoid X receptor-mediated neuroprotection via CYP19 upregulation and subsequent increases in estradiol synthesis. J Steroid Biochem Mol Biol 2019, 193: 105421.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"934_CR43","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.1016\/j.freeradbiomed.2012.03.005","volume":"52","author":"J Guo","year":"2012","unstructured":"Guo J, Duckles SP, Weiss JH, Li X, Krause DN. 17\u03b2-Estradiol prevents cell death and mitochondrial dysfunction by an estrogen receptor-dependent mechanism in astrocytes after oxygen-glucose deprivation\/reperfusion. Free Radic Biol Med 2012, 52: 2151\u20132160.","journal-title":"Free Radic Biol Med"},{"key":"934_CR44","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s00441-018-2817-y","volume":"373","author":"KJ Billingsley","year":"2018","unstructured":"Billingsley KJ, Bandres-Ciga S, Saez-Atienzar S, Singleton AB. Genetic risk factors in Parkinson\u2019s disease. Cell Tissue Res 2018, 373: 9\u201320.","journal-title":"Cell Tissue Res"},{"key":"934_CR45","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/S1474-4422(19)30287-X","volume":"19","author":"C Blauwendraat","year":"2020","unstructured":"Blauwendraat C, Nalls MA, Singleton AB. The genetic architecture of Parkinson\u2019s disease. Lancet Neurol 2020, 19: 170\u2013178.","journal-title":"Lancet Neurol"},{"key":"934_CR46","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1055\/s-0037-1601567","volume":"37","author":"CY Kim","year":"2017","unstructured":"Kim CY, Alcalay RN. Genetic forms of Parkinson\u2019s disease. Semin Neurol 2017, 37: 135\u2013146.","journal-title":"Semin Neurol"},{"key":"934_CR47","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1002\/acn3.489","volume":"4","author":"MS Luciano","year":"2017","unstructured":"Luciano MS, Wang C, Ortega RA, Giladi N, Marder K, Bressman S, et al. Sex differences in LRRK2 G2019S and idiopathic Parkinson\u2019s disease. Ann Clin Transl Neurol 2017, 4: 801\u2013810.","journal-title":"Ann Clin Transl Neurol"},{"key":"934_CR48","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s13073-017-0466-5","volume":"9","author":"YH Chuang","year":"2017","unstructured":"Chuang YH, Paul KC, Bronstein JM, Bordelon Y, Horvath S, Ritz B. Parkinson\u2019s disease is associated with DNA methylation levels in human blood and saliva. Genome Med 2017, 9: 76.","journal-title":"Genome Med"},{"key":"934_CR49","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/nn.4476","volume":"20","author":"TC Fung","year":"2017","unstructured":"Fung TC, Olson CA, Hsiao EY. Interactions between the microbiota, immune and nervous systems in health and disease. Nat Neurosci 2017, 20: 145\u2013155.","journal-title":"Nat Neurosci"},{"key":"934_CR50","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3390\/microorganisms7010014","volume":"7","author":"E Rinninella","year":"2019","unstructured":"Rinninella E, Raoul P, Cintoni M, Franceschi F, Miggiano GAD, Gasbarrini A, et al. What is the healthy gut microbiota composition? A changing ecosystem across age, environment, diet, and diseases. Microorganisms 2019, 7: 14.","journal-title":"Microorganisms"},{"key":"934_CR51","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.3389\/fnins.2019.01032","volume":"13","author":"Y Singh","year":"2019","unstructured":"Singh Y, El-Hadidi M, Admard J, Wassouf Z, Schulze-Hentrich JM, Kohlhofer U, et al. Enriched environmental conditions modify the gut microbiome composition and fecal markers of inflammation in Parkinson\u2019s disease. Front Neurosci 2019, 13: 1032.","journal-title":"Front Neurosci"},{"key":"934_CR52","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s12974-019-1494-4","volume":"16","author":"F Angelucci","year":"2019","unstructured":"Angelucci F, Cechova K, Amlerova J, Hort J. Antibiotics, gut microbiota, and Alzheimer\u2019s disease. J Neuroinflammation 2019, 16: 108.","journal-title":"J Neuroinflammation"},{"key":"934_CR53","doi-asserted-by":"publisher","first-page":"S331","DOI":"10.3233\/JPD-191729","volume":"9","author":"T Brudek","year":"2019","unstructured":"Brudek T. Inflammatory bowel diseases and Parkinson\u2019s disease. J Parkinsons Dis 2019, 9: S331\u2013S344.","journal-title":"J Parkinsons Dis"},{"key":"934_CR54","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1002\/mds.26069","volume":"30","author":"F Scheperjans","year":"2015","unstructured":"Scheperjans F, Aho V, Pereira PAB, Koskinen K, Paulin L, Pekkonen E, et al. Gut microbiota are related to Parkinson\u2019s disease and clinical phenotype. Mov Disord 2015, 30: 350\u2013358.","journal-title":"Mov Disord"},{"key":"934_CR55","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.parkreldis.2016.08.019","volume":"32","author":"MM Unger","year":"2016","unstructured":"Unger MM, Spiegel J, Dillmann KU, Grundmann D, Philippeit H, B\u00fcrmann J, et al. Short chain fatty acids and gut microbiota differ between patients with Parkinson\u2019s disease and age-matched controls. Park Relat Disord 2016, 32: 66\u201372.","journal-title":"Park Relat Disord"},{"key":"934_CR56","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.bbi.2018.02.016","volume":"70","author":"Y Qian","year":"2018","unstructured":"Qian Y, Yang X, Xu S, Wu C, Song Y, Qin N, et al. Alteration of the fecal microbiota in Chinese patients with Parkinson\u2019s disease. Brain Behav Immun 2018, 70: 194\u2013202.","journal-title":"Brain Behav Immun"},{"key":"934_CR57","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1111\/j.1365-2990.2007.00874.x","volume":"33","author":"CH Hawkes","year":"2007","unstructured":"Hawkes CH, Del Tredici K, Braak H. Parkinson\u2019s disease: A dual-hit hypothesis. Neuropathol Appl Neurobiol 2007, 33: 599\u2013614.","journal-title":"Neuropathol Appl Neurobiol"},{"key":"934_CR58","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1093\/brain\/awaa096","volume":"143","author":"ML Arotcarena","year":"2020","unstructured":"Arotcarena ML, Dovero S, Prigent A, Bourdenx M, Camus S, Porras G, et al. Bidirectional gut-to-brain and brain-to-gut propagation of synucleinopathy in non-human Primates. Brain 2020, 143: 1462\u20131475.","journal-title":"Brain"},{"key":"934_CR59","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.neuron.2019.05.035","volume":"103","author":"S Kim","year":"2019","unstructured":"Kim S, Kwon SH, Kam TI, Panicker N, Karuppagounder SS, Lee S, et al. Transneuronal propagation of pathologic \u03b1-synuclein from the gut to the brain models Parkinson\u2019s disease. Neuron 2019, 103: 627-641.e7.","journal-title":"Neuron"},{"key":"934_CR60","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1007\/s00401-019-02040-w","volume":"138","author":"N Van Den Berge","year":"2019","unstructured":"Van Den Berge N, Ferreira N, Gram H, Mikkelsen TW, Alstrup AKO, Casadei N, et al. Evidence for bidirectional and trans-synaptic parasympathetic and sympathetic propagation of alpha-synuclein in rats. Acta Neuropathol 2019, 138: 535\u2013550.","journal-title":"Acta Neuropathol"},{"key":"934_CR61","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1007\/s10517-017-3700-7","volume":"162","author":"VA Petrov","year":"2017","unstructured":"Petrov VA, Saltykova IV, Zhukova IA, Alifirova VM, Zhukova NG, Dorofeeva YB, et al. Analysis of gut microbiota in patients with Parkinson\u2019s disease. Bull Exp Biol Med 2017, 162: 734\u2013737.","journal-title":"Bull Exp Biol Med"},{"key":"934_CR62","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s12915-020-00775-7","volume":"18","author":"F Baldini","year":"2020","unstructured":"Baldini F, Hertel J, Sandt E, Thinnes CC, Neuberger-Castillo L, Pavelka L, et al. Parkinson\u2019s disease-associated alterations of the gut microbiome predict disease-relevant changes in metabolic functions. BMC Biol 2020, 18: 62.","journal-title":"BMC Biol"},{"key":"934_CR63","doi-asserted-by":"publisher","first-page":"67","DOI":"10.14802\/jmd.18067","volume":"12","author":"HL Chiang","year":"2019","unstructured":"Chiang HL, Lin CH. Altered gut microbiome and intestinal pathology in Parkinson\u2019s disease. J Mov Disord 2019, 12: 67\u201383.","journal-title":"J Mov Disord"},{"key":"934_CR64","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1007\/s11427-016-9001-4","volume":"60","author":"W Li","year":"2017","unstructured":"Li W, Wu X, Hu X, Wang T, Liang S, Duan Y, et al. Structural changes of gut microbiota in Parkinson\u2019s disease and its correlation with clinical features. Sci China Life Sci 2017, 60: 1223\u20131233.","journal-title":"Sci China Life Sci"},{"key":"934_CR65","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1002\/mds.26942","volume":"32","author":"EM Hill-Burns","year":"2017","unstructured":"Hill-Burns EM, Debelius JW, Morton JT, Wissemann WT, Lewis MR, Wallen ZD, et al. Parkinson\u2019s disease and Parkinson\u2019s disease medications have distinct signatures of the gut microbiome. Mov Disord 2017, 32: 739\u2013749.","journal-title":"Mov Disord"},{"key":"934_CR66","first-page":"7404","volume":"22","author":"F Mangiola","year":"2018","unstructured":"Mangiola F, Nicoletti A, Gasbarrini A, Ponziani FR. Gut microbiota and aging. Eur Rev Med Pharmacol Sci 2018, 22: 7404\u20137413.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"934_CR67","first-page":"8","volume":"2018","author":"T Fulop","year":"1960","unstructured":"Fulop T, Larbi A, Dupuis G, Le Page A, Frost EH, Cohen AA, et al. Immunosenescence and inflamm-aging As two sides of the same coin: Friends or foes? Front Immunol 1960, 2018: 8.","journal-title":"Front Immunol"},{"key":"934_CR68","first-page":"4038375","volume":"2020","author":"N Palacios","year":"2020","unstructured":"Palacios N, O\u2019Reilly \u00c9J, Schwarzschild MA, Ascherio A. Long-term use of antibiotics and risk of Parkinson\u2019s disease in the nurses\u2019 health study. Parkinsons Dis 2020, 2020: 4038375.","journal-title":"Parkinsons Dis"},{"key":"934_CR69","doi-asserted-by":"publisher","DOI":"10.1016\/j.mehy.2020.109564","volume":"137","author":"G Tern\u00e1k","year":"2020","unstructured":"Tern\u00e1k G, Kuti D, Kov\u00e1cs KJ. Dysbiosis in Parkinson\u2019s disease might be triggered by certain antibiotics. Med Hypotheses 2020, 137: 109564.","journal-title":"Med Hypotheses"},{"key":"934_CR70","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1002\/mds.27924","volume":"35","author":"TH Mertsalmi","year":"2020","unstructured":"Mertsalmi TH, Pekkonen E, Scheperjans F. Antibiotic exposure and risk of Parkinson\u2019s disease in Finland: A nationwide case-control study. Mov Disord 2020, 35: 431\u2013442.","journal-title":"Mov Disord"},{"key":"934_CR71","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s10072-012-1156-0","volume":"34","author":"W Bi","year":"2013","unstructured":"Bi W, Zhu L, Jing X, Liang Y, Tao E. Rifampicin and Parkinson\u2019s disease. Neurol Sci 2013, 34: 137\u2013141.","journal-title":"Neurol Sci"},{"key":"934_CR72","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1007\/s00702-018-1913-1","volume":"125","author":"M Bortolanza","year":"2018","unstructured":"Bortolanza M, Nascimento GC, Socias SB, Ploper D, Cheh\u00edn RN, Raisman-Vozari R, et al. Tetracycline repurposing in neurodegeneration: Focus on Parkinson\u2019s disease. J Neural Transm 2018, 125: 1403\u20131415.","journal-title":"J Neural Transm"},{"key":"934_CR73","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1111\/bph.12139","volume":"169","author":"N Garrido-Mesa","year":"2013","unstructured":"Garrido-Mesa N, Zarzuelo A, G\u00e1lvez J. Minocycline: Far beyond an antibiotic. Br J Pharmacol 2013, 169: 337\u2013352.","journal-title":"Br J Pharmacol"},{"key":"934_CR74","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1186\/s12974-019-1564-7","volume":"16","author":"GC Brown","year":"2019","unstructured":"Brown GC. The endotoxin hypothesis of neurodegeneration. J Neuroinflammation 2019, 16: 180.","journal-title":"J Neuroinflammation"},{"key":"934_CR75","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1186\/s12974-020-02004-y","volume":"17","author":"DF Silva","year":"2020","unstructured":"Silva DF, Candeias E, Esteves AR, Magalh\u00e3es JD, Ferreira IL, Nunes-Costa D, et al. Microbial BMAA elicits mitochondrial dysfunction, innate immunity activation, and Alzheimer\u2019s disease features in cortical neurons. J Neuroinflammation 2020, 17: 332.","journal-title":"J Neuroinflammation"},{"key":"934_CR76","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1016\/j.toxicon.2009.09.023","volume":"55","author":"A Li","year":"2010","unstructured":"Li A, Tian Z, Li J, Yu R, Banack SA, Wang Z. Detection of the neurotoxin BMAA within cyanobacteria isolated from freshwater in China. Toxicon 2010, 55: 947\u2013953.","journal-title":"Toxicon"},{"key":"934_CR77","doi-asserted-by":"publisher","first-page":"180","DOI":"10.3390\/md504180","volume":"5","author":"SA Banack","year":"2007","unstructured":"Banack SA, Johnson HE, Cheng R, Cox PA. Production of the neurotoxin BMAA by a marine cyanobacterium. Mar Drugs 2007, 5: 180\u2013196.","journal-title":"Mar Drugs"},{"key":"934_CR78","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.3390\/toxins6031109","volume":"6","author":"EJ Faassen","year":"2014","unstructured":"Faassen EJ. Presence of the neurotoxin BMAA in aquatic ecosystems: What do we really know? Toxins 2014, 6: 1109\u20131138.","journal-title":"Toxins"},{"key":"934_CR79","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1007\/s12640-017-9753-6","volume":"33","author":"PA Cox","year":"2018","unstructured":"Cox PA, Kostrzewa RM, Guillemin GJ. BMAA and neurodegenerative illness. Neurotox Res 2018, 33: 178\u2013183.","journal-title":"Neurotox Res"},{"key":"934_CR80","doi-asserted-by":"publisher","first-page":"12228","DOI":"10.1073\/pnas.0404926101","volume":"101","author":"SJ Murch","year":"2004","unstructured":"Murch SJ, Cox PA, Banack SA. A mechanism for slow release of biomagnified cyanobacterial neurotoxins and neurodegenerative disease in Guam. Proc Natl Acad Sci U S A 2004, 101: 12228\u201312231.","journal-title":"Proc Natl Acad Sci USA"},{"key":"934_CR81","doi-asserted-by":"publisher","first-page":"26","DOI":"10.3389\/fnagi.2020.00026","volume":"12","author":"D Nunes-Costa","year":"2020","unstructured":"Nunes-Costa D, Magalh\u00e3es JD, G-Fernandes M, Cardoso SM, Empadinhas N. Microbial BMAA and the pathway for Parkinson\u2019s disease neurodegeneration. Front Aging Neurosci 2020, 12: 26.","journal-title":"Front Aging Neurosci"},{"key":"934_CR82","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1007\/s12640-017-9790-1","volume":"33","author":"VX Tan","year":"2018","unstructured":"Tan VX, Lassus B, Lim CK, Tixador P, Courte J, Bessede A, et al. Neurotoxicity of the cyanotoxin BMAA through axonal degeneration and intercellular spreading. Neurotox Res 2018, 33: 62\u201375.","journal-title":"Neurotox Res"},{"key":"934_CR83","doi-asserted-by":"crossref","unstructured":"Esteves AR, Munoz-Pinto MF, Nunes-Costa D, Candeias E, Silva DF, Magalh\u00e3es JD, et al. Footprints of a microbial toxin from the gut microbiome to mesencephalic mitochondria. Gut 2021: gutjnl-2021-326023.","DOI":"10.1136\/gutjnl-2021-326023"},{"key":"934_CR84","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.imbio.2016.07.013","volume":"222","author":"G Marelli","year":"2017","unstructured":"Marelli G, Belgiovine C, Mantovani A, Erreni M, Allavena P. Non-redundant role of the chemokine receptor CX3CR1 in the anti-inflammatory function of gut macrophages. Immunobiology 2017, 222: 463\u2013472.","journal-title":"Immunobiology"},{"key":"934_CR85","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.nbd.2012.07.018","volume":"48","author":"M B\u00f6ttner","year":"2012","unstructured":"B\u00f6ttner M, Zorenkov D, Hellwig I, Barrenschee M, Harde J, Fricke T, et al. Expression pattern and localization of alpha-synuclein in the human enteric nervous system. Neurobiol Dis 2012, 48: 474\u2013480.","journal-title":"Neurobiol Dis"},{"key":"934_CR86","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.cell.2018.07.048","volume":"175","author":"S de Schepper","year":"2018","unstructured":"de Schepper S, Verheijden S, Aguilera-Lizarraga J, Viola MF, Boesmans W, Stakenborg N, et al. Self-maintaining gut macrophages are essential for intestinal homeostasis. Cell 2018, 175: 400-415.e13.","journal-title":"Cell"},{"key":"934_CR87","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1159\/000365417","volume":"7","author":"J Hyun","year":"2015","unstructured":"Hyun J, Romero L, Riveron R, Flores C, Kanagavelu S, Chung KD, et al. Human intestinal epithelial cells express interleukin-10 through Toll-like receptor 4-mediated epithelial-macrophage crosstalk. J Innate Immun 2015, 7: 87\u2013101.","journal-title":"J Innate Immun"},{"key":"934_CR88","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/j.it.2017.07.009","volume":"38","author":"M Regoli","year":"2017","unstructured":"Regoli M, Bertelli E, Gulisano M, Nicoletti C. The multifaceted personality of intestinal CX3CR1+ macrophages. Trends Immunol 2017, 38: 879\u2013887.","journal-title":"Trends Immunol"},{"key":"934_CR89","doi-asserted-by":"publisher","first-page":"15426","DOI":"10.1074\/jbc.M117.788596","volume":"292","author":"K Nakata","year":"2017","unstructured":"Nakata K, Sugi Y, Narabayashi H, Kobayakawa T, Nakanishi Y, Tsuda M, et al. Commensal microbiota-induced microRNA modulates intestinal epithelial permeability through the small GTPase ARF4. J Biol Chem 2017, 292: 15426\u201315433.","journal-title":"J Biol Chem"},{"key":"934_CR90","first-page":"981","volume":"19","author":"X Lu","year":"2020","unstructured":"Lu X, Yu Y, Tan S. The role of the miR-21-5p-mediated inflammatory pathway in ulcerative colitis. Exp Ther Med 2020, 19: 981\u2013989.","journal-title":"Exp Ther Med"},{"key":"934_CR91","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.3748\/wjg.v23.i12.2106","volume":"23","author":"H Van Spaendonk","year":"2017","unstructured":"Van Spaendonk H, Ceuleers H, Witters L, Patteet E, Joossens J, Augustyns K, et al. Regulation of intestinal permeability: The role of proteases. World J Gastroenterol 2017, 23: 2106\u20132123.","journal-title":"World J Gastroenterol"},{"key":"934_CR92","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1007\/s00018-012-1070-x","volume":"70","author":"T Suzuki","year":"2013","unstructured":"Suzuki T. Regulation of intestinal epithelial permeability by tight junctions. Cell Mol Life Sci 2013, 70: 631\u2013659.","journal-title":"Cell Mol Life Sci"},{"key":"934_CR93","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/628157","volume":"2015","author":"A Michielan","year":"2015","unstructured":"Michielan A, D\u2019Inc\u00e0 R. Intestinal permeability in inflammatory bowel disease: Pathogenesis, clinical evaluation, and therapy of leaky gut. Mediators Inflamm 2015, 2015: 628157.","journal-title":"Mediators Inflamm"},{"key":"934_CR94","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1136\/gutjnl-2019-318427","volume":"68","author":"M Camilleri","year":"2019","unstructured":"Camilleri M. Leaky gut: Mechanisms, measurement and clinical implications in humans. Gut 2019, 68: 1516\u20131526.","journal-title":"Gut"},{"key":"934_CR95","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1007\/s00415-019-09320-1","volume":"267","author":"M Lubomski","year":"2020","unstructured":"Lubomski M, Tan AH, Lim SY, Holmes AJ, Davis RL, Sue CM. Parkinson\u2019s disease and the gastrointestinal microbiome. J Neurol 2020, 267: 2507\u20132523.","journal-title":"J Neurol"},{"key":"934_CR96","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1136\/gutjnl-2017-315666","volume":"68","author":"M Villumsen","year":"2019","unstructured":"Villumsen M, Aznar S, Pakkenberg B, Jess T, Brudek T. Inflammatory bowel disease increases the risk of Parkinson\u2019s disease: A Danish nationwide cohort study 1977\u20132014. Gut 2019, 68: 18\u201324.","journal-title":"Gut"},{"key":"934_CR97","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1038\/s41598-018-19646-x","volume":"8","author":"JG Choi","year":"2018","unstructured":"Choi JG, Kim N, Ju IG, Eo H, Lim SM, Jang SE, et al. Oral administration of Proteus mirabilis damages dopaminergic neurons and motor functions in mice. Sci Rep 2018, 8: 1275.","journal-title":"Sci Rep"},{"key":"934_CR98","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.parkreldis.2018.02.022","volume":"50","author":"A Schwiertz","year":"2018","unstructured":"Schwiertz A, Spiegel J, Dillmann U, Grundmann D, B\u00fcrmann J, Fa\u00dfbender K, et al. Fecal markers of intestinal inflammation and intestinal permeability are elevated in Parkinson\u2019s disease. Park Relat Disord 2018, 50: 104\u2013107.","journal-title":"Park Relat Disord"},{"key":"934_CR99","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2019.134516","volume":"712","author":"S Sharma","year":"2019","unstructured":"Sharma S, Awasthi A, Singh S. Altered gut microbiota and intestinal permeability in Parkinson\u2019s disease: Pathological highlight to management. Neurosci Lett 2019, 712: 134516.","journal-title":"Neurosci Lett"},{"key":"934_CR100","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1007\/s10072-019-04217-3","volume":"41","author":"HL Chen","year":"2020","unstructured":"Chen HL, Yamada K, Sakai K, Lu CH, Chen MH, Lin WC. Alteration of brain temperature and systemic inflammation in Parkinson\u2019s disease. Neurol Sci 2020, 41: 1267\u20131276.","journal-title":"Neurol Sci"},{"key":"934_CR101","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1016\/j.cyto.2012.07.030","volume":"60","author":"D Koziorowski","year":"2012","unstructured":"Koziorowski D, Tomasiuk R, Szlufik S, Friedman A. Inflammatory cytokines and NT-proCNP in Parkinson\u2019s disease patients. Cytokine 2012, 60: 762\u2013766.","journal-title":"Cytokine"},{"key":"934_CR102","first-page":"11","volume":"2020","author":"CS Lindestam Arlehamn","year":"1875","unstructured":"Lindestam Arlehamn CS, Dhanwani R, Pham J, Kuan R, Frazier A, Rezende Dutra J, et al. \u03b1-Synuclein-specific T cell reactivity is associated with preclinical and early Parkinson\u2019s disease. Nat Commun 1875, 2020: 11.","journal-title":"Nat Commun"},{"key":"934_CR103","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12974-019-1670-6","volume":"17","author":"Z Fan","year":"2020","unstructured":"Fan Z, Pan YT, Zhang ZY, Yang H, Yu SY, Zheng Y, et al. Systemic activation of NLRP3 inflammasome and plasma \u03b1-synuclein levels are correlated with motor severity and progression in Parkinson\u2019s disease. J Neuroinflammation 2020, 17: 11.","journal-title":"J Neuroinflammation"},{"key":"934_CR104","doi-asserted-by":"publisher","first-page":"210","DOI":"10.3389\/fnagi.2019.00210","volume":"11","author":"B Adams","year":"2019","unstructured":"Adams B, Nunes JM, Page MJ, Roberts T, Carr J, Nell TA, et al. Parkinson\u2019s disease: A systemic inflammatory disease accompanied by bacterial inflammagens. Front Aging Neurosci 2019, 11: 210.","journal-title":"Front Aging Neurosci"},{"key":"934_CR105","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1002\/mds.104","volume":"33","author":"AM Smith","year":"2018","unstructured":"Smith AM, Depp C, Ryan BJ, Johnston GI, Alegre-Abarrategui J, Evetts S, et al. Mitochondrial dysfunction and increased glycolysis in prodromal and early Parkinson\u2019s blood cells. Mov Disord 2018, 33: 1580\u20131590.","journal-title":"Mov Disord"},{"key":"934_CR106","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.3389\/fimmu.2017.01974","volume":"8","author":"C Vida","year":"2018","unstructured":"Vida C, Martinez de Toda I, Garrido A, Carro E, Molina JA, De la Fuente M. Impairment of several immune functions and redox state in blood cells of Alzheimer\u2019s disease patients. Relevant role of neutrophils in oxidative stress. Front Immunol 2018, 8: 1974.","journal-title":"Front Immunol"},{"key":"934_CR107","doi-asserted-by":"publisher","first-page":"452","DOI":"10.3390\/cells8050452","volume":"8","author":"F Guerra","year":"2019","unstructured":"Guerra F, Girolimetti G, Beli R, Mitruccio M, Pacelli C, Ferretta A, et al. Synergistic effect of mitochondrial and lysosomal dysfunction in Parkinson\u2019s disease. Cells 2019, 8: 452.","journal-title":"Cells"},{"key":"934_CR108","doi-asserted-by":"publisher","first-page":"2426","DOI":"10.1002\/acn3.50944","volume":"6","author":"SA Elhadi","year":"2019","unstructured":"Elhadi SA, Grigoletto J, Poli M, Arosio P, Arkadir D, Sharon R. \u03b1-Synuclein in blood cells differentiates Parkinson\u2019s disease from healthy controls. Ann Clin Transl Neurol 2019, 6: 2426\u20132436.","journal-title":"Ann Clin Transl Neurol"},{"key":"934_CR109","doi-asserted-by":"publisher","first-page":"303","DOI":"10.3389\/fimmu.2019.00303","volume":"10","author":"F Garretti","year":"2019","unstructured":"Garretti F, Agalliu D, Lindestam Arlehamn CS, Sette A, Sulzer D. Autoimmunity in Parkinson\u2019s disease: The role of \u03b1-synuclein-specific T cells. Front Immunol 2019, 10: 303.","journal-title":"Front Immunol"},{"key":"934_CR110","doi-asserted-by":"publisher","first-page":"00165","DOI":"10.1183\/23120541.00165-2020","volume":"6","author":"A D'Arrigo","year":"2020","unstructured":"D\u2019Arrigo A, Floro S, Bartesaghi F, Casellato C, Sferrazza Papa GF, Centanni S, et al. Respiratory dysfunction in Parkinson\u2019s disease: A narrative review. ERJ Open Res 2020, 6: 00165\u201302020.","journal-title":"ERJ Open Res"},{"key":"934_CR111","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1038\/s41385-019-0160-6","volume":"12","author":"AT Dang","year":"2019","unstructured":"Dang AT, Marsland BJ. Microbes, metabolites, and the gut\u2013lung axis. Mucosal Immunol 2019, 12: 843\u2013850.","journal-title":"Mucosal Immunol"},{"key":"934_CR112","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak H, Tredici KD, R\u00fcb U, de Vos RAI, Jansen Steur ENH, Braak E. Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiol Aging 2003, 24: 197\u2013211.","journal-title":"Neurobiol Aging"},{"key":"934_CR113","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0028032","volume":"6","author":"CB Forsyth","year":"2011","unstructured":"Forsyth CB, Shannon KM, Kordower JH, Voigt RM, Shaikh M, Jaglin JA, et al. Increased intestinal permeability correlates with sigmoid mucosa alpha-synuclein staining and endotoxin exposure markers in early Parkinson\u2019s disease. PLoS One 2011, 6: e28032.","journal-title":"PLoS One"},{"key":"934_CR114","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.nbd.2011.08.014","volume":"45","author":"H Pouclet","year":"2012","unstructured":"Pouclet H, Lebouvier T, Coron E, Bruley des Varannes S, Rouaud T, Roy M, et al. A comparison between rectal and colonic biopsies to detect Lewy pathology in Parkinson\u2019s disease. Neurobiol Dis 2012, 45: 305\u2013309.","journal-title":"Neurobiol Dis"},{"key":"934_CR115","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1002\/ana.24448","volume":"78","author":"E Svensson","year":"2015","unstructured":"Svensson E, Horv\u00e1th-Puh\u00f3 E, Thomsen RW, Djurhuus JC, Pedersen L, Borghammer P, et al. Vagotomy and subsequent risk of Parkinson\u2019s disease. Ann Neurol 2015, 78: 522\u2013529.","journal-title":"Ann Neurol"},{"key":"934_CR116","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/s41531-022-00295-x","volume":"8","author":"T Warnecke","year":"2022","unstructured":"Warnecke T, Sch\u00e4fer KH, Claus I, Del Tredici K, Jost WH. Gastrointestinal involvement in Parkinson\u2019s disease: Pathophysiology, diagnosis, and management. Npj Park Dis 2022, 8: 31.","journal-title":"Npj Park Dis"},{"key":"934_CR117","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.673395","volume":"9","author":"B Ray","year":"2021","unstructured":"Ray B, Mahalakshmi AM, Tuladhar S, Bhat A, Srinivasan A, Pellegrino C, et al. Janus-faced \u03b1-synuclein: Role in Parkinson\u2019s disease. Front Cell Dev Biol 2021, 9: 673395.","journal-title":"Front Cell Dev Biol"},{"key":"934_CR118","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/1750-1326-7-42","volume":"7","author":"KM Danzer","year":"2012","unstructured":"Danzer KM, Kranich LR, Ruf WP, Cagsal-Getkin O, Winslow AR, Zhu L, et al. Exosomal cell-to-cell transmission of alpha synuclein oligomers. Mol Neurodegener 2012, 7: 42.","journal-title":"Mol Neurodegener"},{"key":"934_CR119","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1038\/nn.4529","volume":"20","author":"T Logan","year":"2017","unstructured":"Logan T, Bendor J, Toupin C, Thorn K, Edwards RH. \u03b1-Synuclein promotes dilation of the exocytotic fusion pore. Nat Neurosci 2017, 20: 681\u2013689.","journal-title":"Nat Neurosci"},{"key":"934_CR120","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s40572-019-00233-9","volume":"6","author":"D Rokad","year":"2019","unstructured":"Rokad D, Jin H, Anantharam V, Kanthasamy A, Kanthasamy AG. Exosomes as mediators of chemical-induced toxicity. Curr Envir Health Rpt 2019, 6: 73\u201379.","journal-title":"Curr Envir Health Rpt"},{"key":"934_CR121","doi-asserted-by":"publisher","first-page":"398","DOI":"10.3389\/fncel.2018.00398","volume":"12","author":"I Garc\u00eda-Dom\u00ednguez","year":"2018","unstructured":"Garc\u00eda-Dom\u00ednguez I, Vesel\u00e1 K, Garc\u00eda-Revilla J, Carrillo-Jim\u00e9nez A, Roca-Ceballos MA, Santiago M, et al. Peripheral inflammation enhances microglia response and nigral dopaminergic cell death in an in vivo MPTP model of Parkinson\u2019s disease. Front Cell Neurosci 2018, 12: 398.","journal-title":"Front Cell Neurosci"},{"key":"934_CR122","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s12868-017-0367-y","volume":"18","author":"PL Chiang","year":"2017","unstructured":"Chiang PL, Chen HL, Lu CH, Chen PC, Chen MH, Yang IH, et al. White matter damage and systemic inflammation in Parkinson\u2019s disease. BMC Neurosci 2017, 18: 48.","journal-title":"BMC Neurosci"},{"key":"934_CR123","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.jns.2009.02.321","volume":"283","author":"BO Popescu","year":"2009","unstructured":"Popescu BO, Toescu EC, Popescu LM, Bajenaru O, Muresanu DF, Schultzberg M, et al. Blood-brain barrier alterations in ageing and dementia. J Neurol Sci 2009, 283: 99\u2013106.","journal-title":"J Neurol Sci"},{"key":"934_CR124","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.addr.2018.04.009","volume":"135","author":"Y Pan","year":"2018","unstructured":"Pan Y, Nicolazzo JA. Impact of aging, Alzheimer\u2019s disease and Parkinson\u2019s disease on the blood-brain barrier transport of therapeutics. Adv Drug Deliv Rev 2018, 135: 62\u201374.","journal-title":"Adv Drug Deliv Rev"},{"key":"934_CR125","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.brainres.2011.01.049","volume":"1382","author":"K Satoh","year":"2011","unstructured":"Satoh K, Niwa M, Goda W, Binh NH, Nakashima M, Takamatsu M, et al. Galectin-3 expression in delayed neuronal death of hippocampal CA1 following transient forebrain ischemia, and its inhibition by hypothermia. Brain Res 2011, 1382: 266\u2013274.","journal-title":"Brain Res"},{"key":"934_CR126","doi-asserted-by":"publisher","first-page":"5816","DOI":"10.1038\/s41467-019-13812-z","volume":"10","author":"K Haruwaka","year":"2019","unstructured":"Haruwaka K, Ikegami A, Tachibana Y, Ohno N, Konishi H, Hashimoto A, et al. Dual microglia effects on blood brain barrier permeability induced by systemic inflammation. Nat Commun 2019, 10: 5816.","journal-title":"Nat Commun"},{"key":"934_CR127","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.neulet.2013.06.058","volume":"551","author":"A Jangula","year":"2013","unstructured":"Jangula A, Murphy EJ. Lipopolysaccharide-induced blood brain barrier permeability is enhanced by alpha-synuclein expression. Neurosci Lett 2013, 551: 23\u201327.","journal-title":"Neurosci Lett"},{"key":"934_CR128","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.3390\/ijms19113573","volume":"19","author":"M Kujawska","year":"2018","unstructured":"Kujawska M, Jodynis-Liebert J. What is the evidence that Parkinson\u2019s disease is a prion disorder, which originates in the gut? Int J Mol Sci 2018, 19: 3573.","journal-title":"Int J Mol Sci"},{"key":"934_CR129","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.peptides.2014.09.018","volume":"62","author":"YT Sui","year":"2014","unstructured":"Sui YT, Bullock KM, Erickson MA, Zhang J, Banks WA. Alpha synuclein is transported into and out of the brain by the blood-brain barrier. Peptides 2014, 62: 197\u2013202.","journal-title":"Peptides"},{"key":"934_CR130","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/jcbfm.2015.32","volume":"35","author":"MT Gray","year":"2015","unstructured":"Gray MT, Woulfe JM. Striatal blood-brain barrier permeability in Parkinson\u2019s disease. J Cereb Blood Flow Metab 2015, 35: 747\u2013750.","journal-title":"J Cereb Blood Flow Metab"},{"key":"934_CR131","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1002\/mds.27804","volume":"34","author":"ME Karakatsani","year":"2019","unstructured":"Karakatsani ME, Blesa J, Konofagou EE. Blood-brain barrier opening with focused ultrasound in experimental models of Parkinson\u2019s disease. Mov Disord 2019, 34: 1252\u20131261.","journal-title":"Mov Disord"},{"key":"934_CR132","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2021.101396","volume":"70","author":"MF Munoz-Pinto","year":"2021","unstructured":"Munoz-Pinto MF, Empadinhas N, Cardoso SM. The neuromicrobiology of Parkinson\u2019s disease: A unifying theory. Ageing Res Rev 2021, 70: 101396.","journal-title":"Ageing Res Rev"}],"container-title":["Neuroscience Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12264-022-00934-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12264-022-00934-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12264-022-00934-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,18]],"date-time":"2023-01-18T06:27:45Z","timestamp":1674023265000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12264-022-00934-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,22]]},"references-count":132,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["934"],"URL":"https:\/\/doi.org\/10.1007\/s12264-022-00934-6","relation":{},"ISSN":["1673-7067","1995-8218"],"issn-type":[{"value":"1673-7067","type":"print"},{"value":"1995-8218","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,22]]},"assertion":[{"value":"16 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All authors claim that there are no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}